(Total Views: 281)
Posted On: 01/28/2022 8:40:53 AM
Post# of 85539

$MRK News Article - Merck and Ridgeback's Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Demonstrated Activity Against Omicron Variant in In Vitro Studies https://marketwirenews.com/news-releases/merc...96162.html


My Twitter: WhyteStocks